Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IGOB131 as a GLP-1 Modulator for Metabolic Disorders in Adults With Obesity
NCT07884058Phase 2Not yet recruiting
- Sponsor
- University of Yaoundé I
- Start
- Dec 2026
- Primary completion
- Oct 2027
01
Overview
A Phase 2 trial of irvingia gabonensis seed extract in obesity, sponsored by University of Yaoundé I. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
irvingia gabonensis seed extract
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07884058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07884058.